CONTEXT: In response to reports of unintentional drug overdoses among children given over-the-counter (OTC) liquid medications, in November 2009 the US Food and Drug Administration (FDA) released new voluntary industry guidelines that recommend greater consistency and clarity in OTC medication dosing directions and their accompanying measuring devices. OBJECTIVE: To determine the prevalence of inconsistent dosing directions and measuring devices among popular pediatric OTC medications at the time the FDA's guidance was released. DESIGN AND SETTING: Descriptive study of 200 top-selling pediatric oral liquid OTC medications during the 52 weeks ending October 30, 2009. Sample represents 99% of the US market of analgesic, cough/cold, allergy, and gastrointestinal OTC oral liquid products with dosing information for children younger than 12 years. MAIN OUTCOME MEASURES: Inclusion of measuring device, within-product inconsistency between dosing directions on the bottle's label and dose markings on enclosed measuring device, across-product use of nonstandard units and abbreviations, and presence of abbreviation definitions. RESULTS: Measuring devices were packaged with 148 of 200 products (74.0%). Within this subset of 148 products, inconsistencies between the medication's dosing directions and markings on the device were found in 146 cases (98.6%). These included missing markings (n = 36, 24.3%) and superfluous markings (n = 120, 81.1%). Across all products, 11 (5.5%) used atypical units of measurement (eg, drams, cc) for doses listed. Milliliter, teaspoon, and tablespoon units were used for doses in 143 (71.5%), 155 (77.5%), and 37 (18.5%) products, respectively. A nonstandard abbreviation for milliliter (not mL) was used by 97 products. Of the products that included an abbreviation, 163 did not define at least 1 abbreviation. CONCLUSION: At the time the FDA released its new guidance, top-selling pediatric OTC liquid medications contained highly variable and inconsistent dosing directions and measuring devices.
CONTEXT: In response to reports of unintentional drug overdoses among children given over-the-counter (OTC) liquid medications, in November 2009 the US Food and Drug Administration (FDA) released new voluntary industry guidelines that recommend greater consistency and clarity in OTC medication dosing directions and their accompanying measuring devices. OBJECTIVE: To determine the prevalence of inconsistent dosing directions and measuring devices among popular pediatric OTC medications at the time the FDA's guidance was released. DESIGN AND SETTING: Descriptive study of 200 top-selling pediatric oral liquid OTC medications during the 52 weeks ending October 30, 2009. Sample represents 99% of the US market of analgesic, cough/cold, allergy, and gastrointestinal OTC oral liquid products with dosing information for children younger than 12 years. MAIN OUTCOME MEASURES: Inclusion of measuring device, within-product inconsistency between dosing directions on the bottle's label and dose markings on enclosed measuring device, across-product use of nonstandard units and abbreviations, and presence of abbreviation definitions. RESULTS: Measuring devices were packaged with 148 of 200 products (74.0%). Within this subset of 148 products, inconsistencies between the medication's dosing directions and markings on the device were found in 146 cases (98.6%). These included missing markings (n = 36, 24.3%) and superfluous markings (n = 120, 81.1%). Across all products, 11 (5.5%) used atypical units of measurement (eg, drams, cc) for doses listed. Milliliter, teaspoon, and tablespoon units were used for doses in 143 (71.5%), 155 (77.5%), and 37 (18.5%) products, respectively. A nonstandard abbreviation for milliliter (not mL) was used by 97 products. Of the products that included an abbreviation, 163 did not define at least 1 abbreviation. CONCLUSION: At the time the FDA released its new guidance, top-selling pediatric OTC liquid medications contained highly variable and inconsistent dosing directions and measuring devices.
Authors: Tiene Bauters; Barbara Claus; Elsie Willems; Johan De Porre; Joris Verlooy; Yves Benoit; Hugo Robays Journal: Int J Clin Pharm Date: 2012-07-10
Authors: Alejandro Torres; Ruth M Parker; Lee M Sanders; Michael S Wolf; Stacy Cooper Bailey; Deesha A Patel; Jessica J Jimenez; Kwang-Youn A Kim; Benard P Dreyer; Alan L Mendelsohn; H Shonna Yin Journal: Acad Pediatr Date: 2017-04-08 Impact factor: 3.107
Authors: Hanna M Seidling; Anette Lampert; Kristina Lohmann; Julia T Schiele; Alexander J F Send; Diana Witticke; Walter E Haefeli Journal: Br J Clin Pharmacol Date: 2013-09 Impact factor: 4.335
Authors: H Shonna Yin; Benard P Dreyer; Hannah A Moreira; Linda van Schaick; Luis Rodriguez; Susanne Boettger; Alan L Mendelsohn Journal: Acad Pediatr Date: 2014 May-Jun Impact factor: 3.107
Authors: H Shonna Yin; Benard P Dreyer; Donna C Ugboaja; Dayana C Sanchez; Ian M Paul; Hannah A Moreira; Luis Rodriguez; Alan L Mendelsohn Journal: Pediatrics Date: 2014-07-14 Impact factor: 7.124
Authors: H Shonna Yin; Ruth M Parker; Lee M Sanders; Benard P Dreyer; Alan L Mendelsohn; Stacy Bailey; Deesha A Patel; Jessica J Jimenez; Kwang-Youn A Kim; Kara Jacobson; Laurie Hedlund; Michelle C J Smith; Leslie Maness Harris; Terri McFadden; Michael S Wolf Journal: Pediatrics Date: 2016-09-12 Impact factor: 7.124
Authors: Tiffany A Williams; Michael S Wolf; Ruth M Parker; Lee M Sanders; Stacy Bailey; Alan L Mendelsohn; Benard P Dreyer; Jessica J Velazquez; H Shonna Yin Journal: J Pediatr Date: 2019-10-08 Impact factor: 4.406
Authors: H Shonna Yin; Alan L Mendelsohn; Perry Nagin; Linda van Schaick; Maria E Cerra; Benard P Dreyer Journal: Acad Pediatr Date: 2013-01-11 Impact factor: 3.107